News tagged with drug therapies
New protein-targeting drug shows promise in early trial for patients with high-risk CLL
A new oral targeted drug, idelalisib (GS-1101), has the potential to stave off the need for additional treatments for relapsed or treatment-resistant chronic lymphocytic leukemia (CLL), according to a study led in part by ...
Cancer
May 17, 2013 |
not rated yet |
0
|
Researchers find potential novel treatment for influenza
An experimental drug has shown promise in treating influenza, preventing lung injury and death from the virus in preclinical studies, according to University of Maryland School of Medicine researchers publishing in the journal ...
Diseases, Conditions, Syndromes
May 01, 2013 |
4.3 / 5 (3) |
0
|
Nearly 5 million asthmatics could benefit from antifungal therapy
An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.
Inflammatory disorders
May 08, 2013 |
not rated yet |
0
Scientists discover new target for personalized cancer therapy
A common cancer pathway causing tumor growth is now being targeted by a number of new cancer drugs and shows promising results. A team of researchers at Case Western Reserve University School of Medicine have developed a ...
Cancer
May 02, 2013 |
5 / 5 (1) |
0
|
Kcentra approved to stop severe bleeding in heart patients
(HealthDay)—Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the anti-clotting drug warfarin and ...
Medications
Apr 30, 2013 |
not rated yet |
0
Cancer studies often lack necessary rigor to answer key questions
Fueled in part by an inclination to speed new treatments to patients, research studies for cancer therapies tend to be smaller and less robust than for other diseases.
Cancer
Apr 29, 2013 |
5 / 5 (1) |
0
New drug stimulates immune system to kill infected cells in animal model of hepatitis B infection
A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of ...
Diseases, Conditions, Syndromes
Apr 26, 2013 |
4.5 / 5 (2) |
0
Therapy helps regenerate child's undeveloped bones
Four years ago, Janelly Martinez-Amador was confined to a bed, unable to move even an arm or lift her head. At age 3, the fragile toddler had the gross motor skills of a newborn and a ventilator kept her ...
Diseases, Conditions, Syndromes
Apr 24, 2013 |
not rated yet |
0
Cancer drugs taking shape
In the era of molecular medicine, potentially active compounds for use in cancer therapies can be identified faster than ever before. Yet pinpointing the molecular target of an anticancer compound and deducing ...
Cancer
Apr 22, 2013 |
not rated yet |
0
Commentary calls for greater transparency in highlighting social value of research
In a commentary published in the May issue of Mayo Clinic Proceedings, UC Davis bioethicist Mark Yarborough proposes that more information about the social value of individual research studies be made available to prospe ...
Other
May 01, 2013 |
not rated yet |
0
Searching for therapeutic synergy in primary effusion lymphoma
Primary effusion lymphoma (PEL) is a rare, fatal form of aggressive B-cell lymphoma caused by Kaposi's sarcoma-associated herpesvirus (KSHV). The disease most commonly occurs in immunocompromised patients, such as those with ...
Cancer
May 01, 2013 |
not rated yet |
0
Indianapolis pharmacy recalls compounded drugs
(AP)—A pharmacy that makes specialty medications is recalling nearly 100 compounded drugs after federal regulators found potential safety problems during an inspection.
Medications
Apr 23, 2013 |
not rated yet |
0
